💉 RETATRUTIDE – 15 MG KIT – 15 MG / VIAL – 1 VIAL – ZPHC PHARMA

💉 Product Type

Peptide / Multi-Agonist Hormonal Therapy / Injectable

💉 Active Ingredient

Retatrutide

💉 Dosage Form

Vial 💉

💉 Description

Retatrutide 15 MG from ZPHC Pharma is a next-generation multi-agonist peptide that targets GLP-1, GIP, and glucagon receptors.

This peptide is designed for advanced research in weight management, metabolic optimization, and type 2 diabetes support, providing insight into how triple agonists influence appetite regulation, insulin sensitivity, and fat metabolism.

💉 Mechanism of Action (How It Works)

• Activates GLP-1 receptors to improve satiety and glucose control
• Activates GIP receptors to enhance insulin sensitivity and lipid metabolism
• Modulates glucagon receptors for optimized energy utilization
• Supports weight loss, fat oxidation, and metabolic regulation
• Enhances overall cellular and metabolic performance

💉 Key Benefits

✅ Supports fat loss and weight management

✅ Enhances insulin sensitivity and glucose regulation

✅ Regulates appetite and energy balance

✅ Promotes metabolic efficiency and overall wellness

💉 Side Effects

⚠ Mild gastrointestinal discomfort (nausea, diarrhea)

⚠ Temporary headache or dizziness

⚠ Injection-site irritation

⚠ Potential changes in blood glucose

💉 Contraindications

❌ Pregnant or breastfeeding women

❌ Individuals with medullary thyroid carcinoma or MEN 2

❌ Severe gastrointestinal disorders

❌ Consult a healthcare provider before use

💉 Important Notes

Retatrutide 15 MG is a research-grade peptide and should be used under medical supervision.

💉 Reconstitution with bacteriostatic water and proper refrigerated storage (2–8°C) is required.

​